Skip to content

Effect of psychoeducation on depression and anxiety symptoms among dialysis patients

Effect of psychoeducation on depression and anxiety symptoms among dialysis patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT138805282353N1
Enrollment
60
Registered
2012-05-17
Start date
2008-07-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: depression. Organic anxiety disorder Recurrent depressive disorder

Interventions

Intervention 1: Three an-hour group education, by a nephrologist and psychiatrist. Content of educational sessions include: 1. Describing the anatomy and pathophysiology, all causes of kidney failure,
Behavior
Three an-hour group education, by a nephrologist and psychiatrist. Content of educational sessions include: 1. Describing the anatomy and pathophysiology, all causes of kidney failure, the advantages
psychoeducation

Sponsors

Mazandaran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: depression or anxiety scores greater or equal to 8 scale HADS patients with renal failure being treated with hemodialysis Exclusion criteria: 1. Experiencing new stressful events during the time of study based on Holmz-Rahe list of stressful life events 2. Any change in the dialysis schedule 3. Starting any other psychiatric treatment during the period of study 4. A known history of previous psychiatric disorder 5. Having a new stressor during previous 6 months except for those related to kidney disease 6. Failure to attend in all educational sessions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Depression. Timepoint: before and 1 week after intervention. Method of measurement: HADS Questionnaire.;Anxiety. Timepoint: before and 1 week after intervention. Method of measurement: HADS Questionnaire.

Secondary

MeasureTime frame
Non. Timepoint: non. Method of measurement: non.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHamzeh Hosseini

Mazandaran University of Medical Sciences

shhosseini@mazums.ac.ir+98 911 124 2487

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026